Qinfan Yao

662 total citations · 1 hit paper
15 papers, 381 citations indexed

About

Qinfan Yao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qinfan Yao has authored 15 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Qinfan Yao's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qinfan Yao is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qinfan Yao collaborates with scholars based in China and United States. Qinfan Yao's co-authors include Xinyu Gu, Xin Yuan, Xue Chen, Zhengyi Bao, Qingmiao Shi, Lanjuan Li, Qingfei Chu, Xiuyuan Zhang, Zheng Li and Cuili Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Advanced Science.

In The Last Decade

Qinfan Yao

14 papers receiving 377 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

2023 310 citations Xue Chen, Qinfan Yao et al. Signal Transduction and Targeted Therapy profile →

Peers

Qinfan Yao

MB

ONCOL

IMMUN

CR

RHEUM

Emira Bousoik United States

Xiwen Dong China

Huilian Huang China

Hugues de Boussac France

Liane Jurida Germany

Xiwu Chen United States

Monika Zajkowska Poland

Ji‐Yoon Ryu South Korea

Jin Gong China

Qi Zhu China

Emira Bousoik United States

Qinfan Yao

215 ×1.2

MB

129 ×1.1

ONCOL

94 ×1.0

IMMUN

62 ×0.7

CR

36 ×1.1

RHEUM

Citations per year, relative to Qinfan Yao Qinfan Yao (= 1×) peers Emira Bousoik

Countries citing papers authored by Qinfan Yao

Since Specialization

Citations

This map shows the geographic impact of Qinfan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinfan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinfan Yao more than expected).

Fields of papers citing papers by Qinfan Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinfan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinfan Yao. The network helps show where Qinfan Yao may publish in the future.

Co-authorship network of co-authors of Qinfan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Qinfan Yao. A scholar is included among the top collaborators of Qinfan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinfan Yao. Qinfan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Yang, Chen, Qinfan Yao, Yuxi Wang, et al.. (2025). Resident Macrophage‐Orchestrated Immune and Fibroblast Interactions in Immune Checkpoint Inhibitor‐Associated Nephrotoxicity. Advanced Science. 12(42). e05445–e05445. 1 indexed citations

2.

Yao, Qinfan, et al.. (2025). Long non-coding RNA NR2F1-AS1: an increasingly significant LncRNA in human cancers. Journal of Physiology and Biochemistry. 81(4). 961–973.

3.

Yao, Qinfan, Xiaoxiao Zheng, Xinyi Zhang, et al.. (2025). METTL3 Potentiates M2 Macrophage‐Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF‐β1/Smad3 Pathway. Advanced Science. 12(11). e2412123–e2412123. 5 indexed citations

4.

Yao, Qinfan, et al.. (2025). Therapeutic potential of p-coumaric acid in alleviating renal fibrosis through inhibition of M2 macrophage infiltration and cellular communication. Phytomedicine. 139. 156507–156507. 2 indexed citations

5.

Yao, Qinfan, Yitong Chen, Xinyi Zhang, et al.. (2025). Decoding m6A RNA methylation in kidney disorders: from molecular insights to therapeutic strategies. Journal of Translational Medicine. 23(1). 771–771. 1 indexed citations

6.

Yao, Qinfan, et al.. (2024). A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma. European journal of medical research. 29(1). 73–73. 2 indexed citations

7.

Yao, Qinfan, et al.. (2024). Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma. European journal of medical research. 29(1). 22–22. 3 indexed citations

8.

Li, Ganglei, Qinfan Yao, Peixi Liu, et al.. (2024). Critical roles and clinical perspectives of RNA methylation in cancer. SHILAP Revista de lepidopterología. 5(5). e559–e559. 17 indexed citations

9.

Yao, Qinfan, Xiuyuan Zhang, Chunchun Wei, et al.. (2023). Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma. Heliyon. 9(6). e17224–e17224. 3 indexed citations

10.

Chen, Xue, Qinfan Yao, Xinyu Gu, et al.. (2023). Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduction and Targeted Therapy. 8(1). 204–204. 310 indexed citations breakdown →

11.

Yao, Qinfan, et al.. (2022). The emerging potentials of lncRNA DRAIC in human cancers. Frontiers in Oncology. 12. 867670–867670. 7 indexed citations

12.

Yao, Qinfan, et al.. (2022). The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases. Clinical & Translational Oncology. 24(12). 2342–2350. 10 indexed citations

13.

Yao, Qinfan, et al.. (2022). Review of LINC00707: A Novel LncRNA and Promising Biomarker for Human Diseases. Frontiers in Cell and Developmental Biology. 10. 813963–813963. 8 indexed citations

14.

Yao, Qinfan, Cuili Wang, Yucheng Wang, et al.. (2022). STXBP3 and GOT2 predict immunological activity in acute allograft rejection. Frontiers in Immunology. 13. 1025681–1025681. 3 indexed citations

15.

Yao, Qinfan, et al.. (2022). Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases. Frontiers in Oncology. 12. 848296–848296. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact